New nomenclature for fatty liver disease

Camilla Dalby Hansen, Katrine Prier Lindvig, Henning Grønbæk, Lise Lotte Gluud, Maja Thiele, Aleksander Krag

Abstract

This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

Bidragets oversatte titelNot Available
OriginalsprogDansk
ArtikelnummerV12230778
TidsskriftUgeskrift for Laeger
Vol/bind186
Udgave nummer19
ISSN0041-5782
DOI
StatusUdgivet - 6 maj 2024

Emneord

  • Humans
  • Terminology as Topic
  • Risk Factors
  • Fatty Liver/classification
  • Fatty Liver, Alcoholic/classification
  • Alcohol Drinking/adverse effects
  • Non-alcoholic Fatty Liver Disease/classification
  • Liver Diseases, Alcoholic/classification

Fingeraftryk

Dyk ned i forskningsemnerne om 'New nomenclature for fatty liver disease'. Sammen danner de et unikt fingeraftryk.

Citationsformater